| - GRCh37:
- Chr17:46023700-46023701
- GRCh38:
- Chr17:47946334-47946335
| PNPO | N188fs | Pyridoxal phosphate-responsive seizures | Likely pathogenic (Apr 17, 2023) | criteria provided, single submitter |
| - GRCh37:
- Chr17:46019042-46024148
| PNPO | | Pyridoxal phosphate-responsive seizures | Uncertain significance (Nov 22, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr17:46019042-46024148
| PNPO | | Pyridoxal phosphate-responsive seizures | Pathogenic (Jun 14, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr17:46019171
- GRCh38:
- Chr17:47941805
| PNPO | D44H | Pyridoxal phosphate-responsive seizures | Uncertain significance (Jul 19, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr17:46024108
- GRCh38:
- Chr17:47946742
| PNPO | R249H | Pyridoxal phosphate-responsive seizures | Uncertain significance (Aug 10, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr17:46023961
- GRCh38:
- Chr17:47946595
| PNPO | | Pyridoxal phosphate-responsive seizures | Likely benign (Oct 17, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr17:46024014
- GRCh38:
- Chr17:47946648
| PNPO | F218L | Pyridoxal phosphate-responsive seizures | Uncertain significance (Mar 1, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr17:46019187
- GRCh38:
- Chr17:47941821
| PNPO | | Pyridoxal phosphate-responsive seizures | Likely benign (Feb 19, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr17:46021979
- GRCh38:
- Chr17:47944613
| PNPO | | Pyridoxal phosphate-responsive seizures | Uncertain significance (Mar 13, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr17:46023230
- GRCh38:
- Chr17:47945864
| PNPO | R141C | Pyridoxal phosphate-responsive seizures | Uncertain significance (May 5, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr17:46023230-46023241
- GRCh38:
- Chr17:47945864-47945875
| PNPO | | Pyridoxal phosphate-responsive seizures | Uncertain significance (Apr 20, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr17:46020806
- GRCh38:
- Chr17:47943440
| PNPO | | Pyridoxal phosphate-responsive seizures | Likely benign (Aug 23, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr17:46023318
- GRCh38:
- Chr17:47945952
| PNPO | V170A | Pyridoxal phosphate-responsive seizures | Uncertain significance (Apr 16, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr17:46022072
- GRCh38:
- Chr17:47944706
| PNPO | | Pyridoxal phosphate-responsive seizures | Likely benign (Mar 19, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr17:46024054
- GRCh38:
- Chr17:47946688
| PNPO | V231D | Pyridoxal phosphate-responsive seizures | Uncertain significance (Jun 14, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr17:46022955
- GRCh38:
- Chr17:47945589
| PNPO | Y132H | Pyridoxal phosphate-responsive seizures | Uncertain significance (Feb 20, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr17:46019124
- GRCh38:
- Chr17:47941758
| PNPO | R28L | Pyridoxal phosphate-responsive seizures | Uncertain significance (Mar 19, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr17:46022019
- GRCh38:
- Chr17:47944653
| PNPO | G101S | Pyridoxal phosphate-responsive seizures | Uncertain significance (Oct 5, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr17:46020687
- GRCh38:
- Chr17:47943321
| PNPO | H52Y | Pyridoxal phosphate-responsive seizures | Uncertain significance (Jun 4, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr17:46022022
- GRCh38:
- Chr17:47944656
| PNPO | F102V | Pyridoxal phosphate-responsive seizures | Uncertain significance (Dec 20, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr17:46020755
- GRCh38:
- Chr17:47943389
| PNPO | | Pyridoxal phosphate-responsive seizures | Likely benign (Oct 8, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr17:46022985
- GRCh38:
- Chr17:47945619
| PNPO | | Pyridoxal phosphate-responsive seizures | Likely benign (Sep 26, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr17:46020775
- GRCh38:
- Chr17:47943409
| PNPO | M81K | Pyridoxal phosphate-responsive seizures | Uncertain significance (Oct 17, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr17:46024021
- GRCh38:
- Chr17:47946655
| PNPO | Q220R | Pyridoxal phosphate-responsive seizures | Uncertain significance (Dec 8, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr17:46020777
- GRCh38:
- Chr17:47943411
| PNPO | C82R | Pyridoxal phosphate-responsive seizures | Uncertain significance (Jun 8, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr17:46020695
- GRCh38:
- Chr17:47943329
| PNPO | | Pyridoxal phosphate-responsive seizures | Likely benign (May 24, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr17:46019155
- GRCh38:
- Chr17:47941789
| PNPO | | Pyridoxal phosphate-responsive seizures | Uncertain significance (Jul 19, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr17:46023307
- GRCh38:
- Chr17:47945941
| PNPO | | Pyridoxal phosphate-responsive seizures | Likely benign (Jul 19, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr17:46023365
- GRCh38:
- Chr17:47945999
| PNPO | | Pyridoxal phosphate-responsive seizures | Likely benign (Jul 19, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr17:46023990
- GRCh38:
- Chr17:47946624
| PNPO | V210L | Pyridoxal phosphate-responsive seizures | Uncertain significance (Aug 9, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr17:46023248
- GRCh38:
- Chr17:47945882
| PNPO | K147E | Pyridoxal phosphate-responsive seizures | Uncertain significance (May 5, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr17:46019080
- GRCh38:
- Chr17:47941714
| PNPO | | Pyridoxal phosphate-responsive seizures | Likely benign (Jun 17, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr17:46023979
- GRCh38:
- Chr17:47946613
| PNPO | | Pyridoxal phosphate-responsive seizures | Pathogenic (Sep 8, 2002) | no assertion criteria provided |
| - GRCh37:
- Chr17:46023356
- GRCh38:
- Chr17:47945990
| PNPO | | Pyridoxal phosphate-responsive seizures | Pathogenic (Sep 8, 2002) | no assertion criteria provided |
| - GRCh37:
- Chr17:46023226
- GRCh38:
- Chr17:47945860
| PNPO | | Pyridoxal phosphate-responsive seizures | Likely pathogenic (Aug 6, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr17:46022996
- GRCh38:
- Chr17:47945630
| PNPO | | Pyridoxal phosphate-responsive seizures | Likely benign (Aug 31, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr17:46020665
- GRCh38:
- Chr17:47943299
| PNPO | | Pyridoxal phosphate-responsive seizures | Likely benign (Jul 12, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr17:46022099-46022112
- GRCh38:
- Chr17:47944733-47944746
| PNPO | | Pyridoxal phosphate-responsive seizures | Likely benign (Nov 11, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr17:46021963
- GRCh38:
- Chr17:47944597
| PNPO | | Pyridoxal phosphate-responsive seizures | Likely benign (Sep 13, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr17:46023998
- GRCh38:
- Chr17:47946632
| PNPO | | Pyridoxal phosphate-responsive seizures | Likely benign (Sep 20, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr17:46023259
- GRCh38:
- Chr17:47945893
| PNPO | | Pyridoxal phosphate-responsive seizures | Likely benign (Oct 17, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr17:46022057
- GRCh38:
- Chr17:47944691
| PNPO | | Pyridoxal phosphate-responsive seizures | Likely benign (Dec 3, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr17:46023679
- GRCh38:
- Chr17:47946313
| PNPO | | Pyridoxal phosphate-responsive seizures | Likely benign (Jan 6, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr17:46022995
- GRCh38:
- Chr17:47945629
| PNPO | | Pyridoxal phosphate-responsive seizures | Likely benign (Oct 25, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr17:46023313
- GRCh38:
- Chr17:47945947
| PNPO | | Pyridoxal phosphate-responsive seizures | Likely benign (Nov 7, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr17:46022051
- GRCh38:
- Chr17:47944685
| PNPO | | Pyridoxal phosphate-responsive seizures | Likely benign (Aug 19, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr17:46023319
- GRCh38:
- Chr17:47945953
| PNPO | | Pyridoxal phosphate-responsive seizures | Likely benign (Sep 12, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr17:46019187
- GRCh38:
- Chr17:47941821
| PNPO | | Pyridoxal phosphate-responsive seizures | Likely benign (Jun 20, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr17:46022101
- GRCh38:
- Chr17:47944735
| PNPO | | Pyridoxal phosphate-responsive seizures | Likely benign (Feb 10, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr17:46022074
- GRCh38:
- Chr17:47944708
| PNPO | K119R | Pyridoxal phosphate-responsive seizures | Uncertain significance (Jun 20, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr17:46023747
- GRCh38:
- Chr17:47946381
| PNPO | K202R | Pyridoxal phosphate-responsive seizures | Uncertain significance (Oct 13, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr17:46020769
- GRCh38:
- Chr17:47943403
| PNPO | N79S | Pyridoxal phosphate-responsive seizures | Uncertain significance (Jul 12, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr17:46022028
- GRCh38:
- Chr17:47944662
| PNPO | K104E | Pyridoxal phosphate-responsive seizures | Uncertain significance (Aug 14, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr17:46023777
- GRCh38:
- Chr17:47946411
| PNPO | | Pyridoxal phosphate-responsive seizures | Likely benign (Aug 10, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr17:46020799
- GRCh38:
- Chr17:47943433
| PNPO | | Pyridoxal phosphate-responsive seizures | Uncertain significance (Oct 27, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr17:46023725
- GRCh38:
- Chr17:47946359
| PNPO | Y195H | Pyridoxal phosphate-responsive seizures | Uncertain significance (Nov 9, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr17:46019168
- GRCh38:
- Chr17:47941802
| PNPO | G43R | Pyridoxal phosphate-responsive seizures | Uncertain significance (Oct 24, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr17:46020802
- GRCh38:
- Chr17:47943436
| PNPO | | Pyridoxal phosphate-responsive seizures | Uncertain significance (Dec 23, 2020) | criteria provided, single submitter |
| - GRCh37:
- Chr17:46024110
- GRCh38:
- Chr17:47946744
| PNPO | E251fs | Pyridoxal phosphate-responsive seizures | Uncertain significance (Jul 18, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr17:46023687
- GRCh38:
- Chr17:47946321
| PNPO | | Pyridoxal phosphate-responsive seizures | Likely pathogenic (Jul 17, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr17:46022961
- GRCh38:
- Chr17:47945595
| PNPO | E134Q | Pyridoxal phosphate-responsive seizures | Uncertain significance (Aug 31, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr17:46022984
- GRCh38:
- Chr17:47945618
| PNPO | | Pyridoxal phosphate-responsive seizures | Uncertain significance (Jun 1, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr17:46023240
- GRCh38:
- Chr17:47945874
| PNPO | G144D | Pyridoxal phosphate-responsive seizures | Uncertain significance (Oct 13, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr17:46022064
- GRCh38:
- Chr17:47944698
| PNPO | R116* | Pyridoxal phosphate-responsive seizures | Pathogenic (Feb 3, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr17:46019153
- GRCh38:
- Chr17:47941787
| PNPO | R38S | Pyridoxal phosphate-responsive seizures | Uncertain significance (Aug 16, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr17:46024029
- GRCh38:
- Chr17:47946663
| PNPO | T223A | Pyridoxal phosphate-responsive seizures | Uncertain significance (Sep 1, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr17:46019165
- GRCh38:
- Chr17:47941799
| PNPO | R42C | Pyridoxal phosphate-responsive seizures | Uncertain significance (Feb 9, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr17:46020797
- GRCh38:
- Chr17:47943431
| PNPO | | Pyridoxal phosphate-responsive seizures | Pathogenic (Jul 14, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr17:46020738
- GRCh38:
- Chr17:47943372
| PNPO | A69T | Pyridoxal phosphate-responsive seizures | Uncertain significance (Sep 1, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr17:46019063
- GRCh38:
- Chr17:47941697
| PNPO | V8I | Pyridoxal phosphate-responsive seizures | Uncertain significance (Jun 27, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr17:46023294
- GRCh38:
- Chr17:47945928
| PNPO | P162L | Pyridoxal phosphate-responsive seizures | Uncertain significance (Dec 15, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr17:46020796
- GRCh38:
- Chr17:47943430
| PNPO | R88I | Pyridoxal phosphate-responsive seizures | Uncertain significance (Feb 10, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr17:46024080
- GRCh38:
- Chr17:47946714
| PNPO | D240Y | Pyridoxal phosphate-responsive seizures | Uncertain significance (Feb 17, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr17:46019057
- GRCh38:
- Chr17:47941691
| PNPO | R6W | Pyridoxal phosphate-responsive seizures | Uncertain significance (Jan 11, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr17:46024063
- GRCh38:
- Chr17:47946697
| PNPO | R234Q | Pyridoxal phosphate-responsive seizures, Inborn genetic diseases | Uncertain significance (Aug 19, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr17:46020693
- GRCh38:
- Chr17:47943327
| PNPO | T54S | Pyridoxal phosphate-responsive seizures | Uncertain significance (Sep 2, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr17:46024107
- GRCh38:
- Chr17:47946741
| PNPO | R249C | Pyridoxal phosphate-responsive seizures | Uncertain significance (Feb 5, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr17:46019175
- GRCh38:
- Chr17:47941809
| PNPO | R45Q | Pyridoxal phosphate-responsive seizures | Uncertain significance (Oct 20, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr17:46023315
- GRCh38:
- Chr17:47945949
| PNPO | A169V | Pyridoxal phosphate-responsive seizures | Uncertain significance (Apr 22, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr17:46020711
- GRCh38:
- Chr17:47943345
| PNPO | K60* | Pyridoxal phosphate-responsive seizures | Pathogenic (Mar 17, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr17:46023297
- GRCh38:
- Chr17:47945931
| PNPO | K163R | Inborn genetic diseases, Pyridoxal phosphate-responsive seizures, not provided
| Uncertain significance (Jun 28, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr17:46019124
- GRCh38:
- Chr17:47941758
| PNPO | R28H | Pyridoxal phosphate-responsive seizures, not provided | Uncertain significance (Jul 26, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr17:46024074
- GRCh38:
- Chr17:47946708
| PNPO | T238A | not provided, Pyridoxal phosphate-responsive seizures | Uncertain significance (Apr 17, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr17:46022001
- GRCh38:
- Chr17:47944635
| PNPO | R95C | Pyridoxal phosphate-responsive seizures | Pathogenic/Likely pathogenic (Oct 26, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr17:46024109
- GRCh38:
- Chr17:47946743
| PNPO | | Pyridoxal phosphate-responsive seizures, not provided | Benign/Likely benign (Mar 19, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr17:46022963
- GRCh38:
- Chr17:47945597
| PNPO | | Pyridoxal phosphate-responsive seizures | Likely benign (Aug 18, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr17:46023229
- GRCh38:
- Chr17:47945863
| PNPO | | Pyridoxal phosphate-responsive seizures | Likely benign (Feb 3, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr17:46022060
- GRCh38:
- Chr17:47944694
| PNPO | | Pyridoxal phosphate-responsive seizures | Likely benign (Aug 22, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr17:46023343
- GRCh38:
- Chr17:47945977
| PNPO | | Pyridoxal phosphate-responsive seizures | Likely benign (Oct 18, 2019) | criteria provided, single submitter |
| - GRCh37:
- Chr17:46022000
- GRCh38:
- Chr17:47944634
| PNPO | | Pyridoxal phosphate-responsive seizures | Likely benign (Oct 23, 2020) | criteria provided, single submitter |
| - GRCh37:
- Chr17:46023247
- GRCh38:
- Chr17:47945881
| PNPO | | Inborn genetic diseases, Pyridoxal phosphate-responsive seizures | Likely benign (Oct 1, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr17:46024055
- GRCh38:
- Chr17:47946689
| PNPO | | Pyridoxal phosphate-responsive seizures | Likely benign (Oct 25, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr17:46023316
- GRCh38:
- Chr17:47945950
| PNPO | | Pyridoxal phosphate-responsive seizures | Likely benign (Jul 18, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr17:46023262
- GRCh38:
- Chr17:47945896
| PNPO | | Pyridoxal phosphate-responsive seizures | Likely benign (Jun 29, 2020) | criteria provided, single submitter |
| - GRCh37:
- Chr17:46023970
- GRCh38:
- Chr17:47946604
| PNPO | | Pyridoxal phosphate-responsive seizures | Likely benign (Jan 15, 2020) | criteria provided, single submitter |
| - GRCh37:
- Chr17:46020689
- GRCh38:
- Chr17:47943323
| PNPO | | Pyridoxal phosphate-responsive seizures | Likely benign (Jan 26, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr17:46022015
- GRCh38:
- Chr17:47944649
| PNPO | | Pyridoxal phosphate-responsive seizures | Likely benign (Dec 24, 2019) | criteria provided, single submitter |
| - GRCh37:
- Chr17:46021985
- GRCh38:
- Chr17:47944619
| PNPO | | Pyridoxal phosphate-responsive seizures | Likely benign (Jun 27, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr17:46023218
- GRCh38:
- Chr17:47945852
| PNPO | | Pyridoxal phosphate-responsive seizures | Likely benign (Aug 21, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr17:46019107
- GRCh38:
- Chr17:47941741
| PNPO | | Pyridoxal phosphate-responsive seizures | Likely benign (Mar 11, 2022) | criteria provided, single submitter |